Evidence map›Paper›PMID 23597332›Full record

Trial reportJournal of psychosomatic research2013

Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life.

Tanya M Spruill, Seth D Feltheimer, Manjunath Harlapur, Joseph E Schwartz, Gbenga Ogedegbe, Youngjun Park, William Gerin

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of psychosomatic research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Beliefs about the causes of hypertension and associations with pro-health behaviors.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2018
    Article
  9. Review
  10. Quality of Life in Treatment-Resistant Hypertension.Current hypertension reports · 2015
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tanya M SpruillCenter for Healthful Behavior Change, Department of Population Health, New York University School of Medicine, USA. tanya.spruill@nyumc.org
Seth D Feltheimer
Manjunath Harlapur
Joseph E Schwartz
Gbenga Ogedegbe
Youngjun Park
William Gerin

Funding

WORKSITE BLOOD PRESSURE STUDYP01HL047540 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI SCHWARTZ, JOSEPH E · 1993 to 2014
$27.7M
MIND-BODY-BEHAVIORAL MED CLINICAL TRIALS INFRASTRUCTURER24HL076857 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DAVIDSON, KARINA W. · 2004 to 2008
$3.5M
Midcareer Investigator Award in Patient-Oriented Research for Dr. Gbenga OgedegbeK24HL111315 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OGEDEGBE, OLUGBENGA G. · 2012 to 2016
$621k
Diagnostic Labeling: Effect on White Coat HypertensionK23HL086734 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPRUILL, TANYA M · 2007 to 2010
$607k
NHLBI NIH HHS K23 HL086734NHLBI NIH HHS K23HL086734NHLBI NIH HHS K24 HL111315NHLBI NIH HHS P01 HL047540NHLBI NIH HHS P01HL47540NHLBI NIH HHS R24 HL076857NHLBI NIH HHS R24HL76857
6 · The paper itself

Abstract

objectiveThe prehypertension classification was introduced to facilitate prevention efforts among patients at increased risk for hypertension. Although patients who have been told that they have hypertension report worse outcomes than unaware hypertensives, little is known about whether or not prehypertension labeling has negative effects. We evaluated the effects of labeling individuals with prehypertension on blood pressure and health-related quality of life three months later.

methodsOne hundred adults (aged 19 to 82 [mean=40.0] years; 54% women; 64% racial/ethnic minorities) with screening blood pressure in the prehypertensive range (120-139/80-89 mmHg) and no history of diagnosis or treatment of elevated blood pressure were randomly assigned to either a "Labeled" group in which they were informed of their prehypertension, or an "Unlabeled" group in which they were not informed. Subjects underwent office blood pressure measurement, 24-hour ambulatory blood pressure monitoring and completed self-report questionnaires at baseline and at three months.

resultsMultilevel mixed effects regression analyses indicated that changes in the white coat effect, office blood pressure, mean daytime ambulatory blood pressure, and physical and mental health did not differ significantly between the two groups. Adjusting for age, sex, race/ethnicity and body mass index did not affect the results.

conclusionThese findings suggest that labeling patients with prehypertension does not have negative effects on blood pressure or quality of life. Additional research is needed to develop approaches to communicating with patients about their blood pressure that will maximize the clinical and public health impact of the prehypertension classification.

Indexed as

Blood PressureCommunicationPatient Education as TopicAdaptation, PsychologicalAdultAttitude to HealthAwarenessFemaleHumansMaleMiddle AgedPrehypertensionQuality of LifeWhite Coat Hypertension

Identifiers

PMID23597332
PMCPMC3631319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.